(Q52915059)

9 May 2018

title

Small-cell lung cancer: patients included in clinical trials are not representative of the patient population as a whole. (English)

1 reference

9 May 2018

0 references

1 reference

V Cottin

1

1 reference

9 May 2018

D Arpin

2

1 reference

9 May 2018

C Lasset

3

1 reference

9 May 2018

J F Cordier

4

1 reference

9 May 2018

J Brune

5

1 reference

9 May 2018

F Chauvin

6

1 reference

9 May 2018

V Trillet-Lenoir

7

1 reference

9 May 2018

publication date

1 July 1999

1 reference

9 May 2018

published in

Annals of Oncology

1 reference

9 May 2018

volume

10

1 reference

9 May 2018

issue

7

1 reference

9 May 2018

page(s)

809-815

1 reference

9 May 2018

Sick population--treated population: the need for a better definition. The VALIDATA Group

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Accrual of radiotherapy patients to clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Prognosis at presentation of small cell carcinoma of the lung

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Treatment of small-cell lung cancer on protocol: potential bias of results.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Limited disease small cell lung cancer: alternating combination of doxorubicin, etoposide, ifosfamide and hyperfractionated radiotherapy. Final results of a multicentric pilot study for the Groupe Lyonnias d'Oncologie Thoracique (GLOT)

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Hyperfractionated radiotherapy alternating with multidrug chemotherapy in the treatment of limited small cell lung cancer (SCLC). Groupe Lyonnais d'Oncologie Thoracique

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Nonparametric Estimation from Incomplete Observations

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Cancer treatment protocols. Who gets chosen?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

A New Design for Randomized Clinical Trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Physicians' reasons for not entering eligible patients in a randomized clinical trial of surgery for breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

An overview of prognostic factors in small cell lung cancer. A report from the Subcommittee for the Management of Lung Cancer of the United Kingdom Coordinating Committee on Cancer Research

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Cancer in the elderly: why so badly treated?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Evaluation of the informed consent procedure in cancer patients candidate to immunotherapy

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Information and participation preferences among cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decision making

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Determinants of improved outcome in small-cell lung cancer: an analysis of the 2,580-patient Southwest Oncology Group data base

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Clinical and serologic markers of stage and prognosis in small cell lung cancer. A multivariate analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Prognostic factors in small-cell carcinoma of the lung: an analysis of 1,521 patients.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Small-cell carcinoma of the lung: derivation of a prognostic staging system

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Do treatment protocols improve end results? A study of survival of patients with multiple myeloma in Finland

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1008399831512

7 January 2021

Identifiers

DOI

10.1023/A:1008399831512

1 reference

9 May 2018

1 reference

9 May 2018